Tag: AOM Infusion
In brief: Revelstoke recaps AOM, Vivos to make buy, state legislation makes tracks
April 18, 2025HME News Staff
DENVER – Revelstoke Capital Partners, a health care-focused private equity firm, has completed a recapitalization of AOM Infusion, a specialty infusion provider of chronic therapy management.
AOM Infusion provides patients with intravenous immunoglobulin, biologics and other therapies, addressing more than 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The company also provides support services, including skilled infusion...
Revelstoke recaps AOM Infusion
April 15, 2025HME News Staff
DENVER – Revelstoke Capital Partners, a growth-oriented health care-focused private equity firm, has completed a recapitalization of AOM Infusion, a specialty infusion provider focused on chronic therapy management.
AOM Infusion provides patients with intravenous immunoglobulin, biologics and other therapies, addressing more than 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The company also provides support services, including skilled...
In brief: AdaptHealth’s static revenue, bid program’s impact, AOM’s Western expansion
November 6, 2024HME News Staff
PLYMOUTH MEETING, Pa. – AdaptHealth reported third quarter net revenue of $805.9 million compared to $804 million, an increase of 0.2% year over year.
Net income attributable to AdaptHealth was $22.9 million vs. a net loss of $454.1 million. Adjusted EBITDA was $164.3 million vs. $161.2 million, an increase of 1.9%
“I continue to be optimistic about the road ahead,” said Suzanne Foster, CEO. “We have identified growth opportunities, we are assembling a high...
AOM strengthens presence out West
November 5, 2024HME News Staff
ARLINGTON, Va. – AOM Infusion is expanding its presence in Arizona, Michigan and Washington. The company says it is committed to developing strong partnerships with local health care providers, health systems and payers across the Southwest, Pacific Northwest and Midwest. “We are really proud of the growth the company has experienced over the past year,” said Keyur Mehta, CEO of AOM Infusion. “Strengthening our presence in these regions and strategically adding ambulatory...
AOM names new CEO
May 8, 2023HME News Staff
CHARLOTTE, N.C. – AOM Infusion, which provides home-based intravenous immunoglobulin IVIG therapy to patients with more than 80 different chronic conditions, has named Keyur Mehta as CEO. Christopher York will continue in his position as chairman of the company. “Keyur is an experienced specialty infusion executive and we have been impressed by his operational and team building capabilities,” said Petri Lindberg, Principal at Ridgemont Equity Partners, which bought AOM in 2022....